T2 Biosystems Inc Ret. sull'asset
Cos'è Ret. sull'asset di T2 Biosystems Inc?
Ret. sull'asset di T2 Biosystems Inc è -154.99%
Qual è la definizione di Ret. sull'asset?
Il rendimento delle attività indica quanto redditizie le attività di un'azienda stanno generando entrate. Viene calcolato dividendo il reddito netto per il patrimonio medio totale.
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
Ret. sull'asset di aziende nel Health Care settore su NASDAQ rispetto a T2 Biosystems Inc
Cosa fa T2 Biosystems Inc?
t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our initial development efforts target sepsis, hemostasis, bacteria and lyme disease, which are areas of significant unmet medical need. the company is utilizing its proprietary t2 magnetic resonance platform, or t2mr®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. at t2 biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. we invite you to apply for one of our open positions at www
Aziende con ret. sull'asset simili a T2 Biosystems Inc
- Organovo Inc ha Ret. sull'asset di -156.01%
- Carespan Health Inc ha Ret. sull'asset di -155.96%
- Lexagene ha Ret. sull'asset di -155.93%
- Lexagene ha Ret. sull'asset di -155.93%
- Curzon Plc ha Ret. sull'asset di -155.88%
- The Flowr ha Ret. sull'asset di -155.23%
- T2 Biosystems Inc ha Ret. sull'asset di -154.99%
- Endexx ha Ret. sull'asset di -154.76%
- Bio-Key International ha Ret. sull'asset di -154.73%
- WestKam Gold ha Ret. sull'asset di -154.56%
- GLG Life Tech ha Ret. sull'asset di -154.38%
- Iconic Labs Plc ha Ret. sull'asset di -153.91%
- Equatorial Palm Oil plc ha Ret. sull'asset di -153.64%